Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure

Arch Dermatol. 2006 Feb;142(2):252-3. doi: 10.1001/archderm.142.2.252.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Prospective Studies
  • Tacrolimus / therapeutic use*
  • Treatment Outcome
  • Ultraviolet Rays
  • Vitiligo / drug therapy*
  • Vitiligo / pathology

Substances

  • Immunosuppressive Agents
  • Tacrolimus